InvestorsHub Logo

DR. EVIL

11/07/15 12:15 PM

#32153 RE: wildcard235 #32151

Strong work!

Thank you!

scottsmith

11/07/15 12:18 PM

#32155 RE: wildcard235 #32151

Thanks wildcard. If you could, please answer this question:

The July 22 results showed that P 300 increased by 38 percent, which is 4 times higher than Aricept at the same point in time. The Barcelona results show P 300 increased by 80 percent from baseline.

Does that mean 2-73 is even more than 4 times greater than Aricept for that metric?

Thanks.

Lenivec

11/07/15 12:21 PM

#32156 RE: wildcard235 #32151

Excellent.. Thank you.. Very important "This evidence provides sufficient confidence to start a larger randomized, double-blind Phase 2/3 study"

twiz0019

11/07/15 12:25 PM

#32158 RE: wildcard235 #32151

AWESOME analysis wildcard....extremely impressive job!

stealthways

11/07/15 12:31 PM

#32159 RE: wildcard235 #32151

best summation of available slides I have seen...

Thank you and all the best

e024355

11/07/15 12:36 PM

#32165 RE: wildcard235 #32151

Wild,
Great post. I believe you have an error with this statement. "Result: 11 of 14 patients (78.6%) improved 3.21 pts, from approximately 64 to 66.2." Wouldn't the new value be 64+3.21 = 67.21?

JB3729

11/07/15 1:16 PM

#32195 RE: wildcard235 #32151

Excellent!!! Thanks for putting that together wildcard235!

bigstocksnbonds

11/07/15 1:55 PM

#32218 RE: wildcard235 #32151

Thanks So Much for that great analysis and Summary! Much appreciated!!! AVXL $$$$$$$$

WellSpring

11/07/15 2:14 PM

#32232 RE: wildcard235 #32151

This is great; thank you.

kc2code

11/08/15 9:36 AM

#32476 RE: wildcard235 #32151

minor nitpick it's 12 days on, 11 days washout, then 11 days on according to clinical trials.

Just my OCD kicking in :-)

The first period will involve 12 administrations (either oral or iv) and the second period will involve 11 administrations (either oral or iv).